State Street Corp Xeris Biopharma Holdings, Inc. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, State Street Corp holds 3,341,874 shares of XERS stock, worth $13.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,341,874
Previous 3,204,718
4.28%
Holding current value
$13.3 Million
Previous $9.13 Million
24.03%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$31.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$13.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$11.4 Million0.0% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.57MShares$10.2 Million3.53% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $540M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...